CTN webinar: Secondary analyses for clinical trials in development.

This 90 minute webinar, produced by the National Drug Abuse Treatment Clinical Trials Network (CTN) Clinical Coordinating Center for CTN members and the public, discusses secondary analysis planning in the development of clinical trials, interpretation, and reporting. Additionally, there is consideration of the balance between hypothesis generation and maintaining the overall integrity of the trial when secondary analysis occurs after study completion.

Objectives include:

– Reviewing the statistical issues with analyzing/interpreting secondary analyses;

– Explaining the importance of secondary outcome and analysis identification during protocol development;

– Discussing reporting and interpretation of secondary analyses, including the perspective of the CTN Publications Committee.

Presented by Abigail Matthews, PhD (EMMES Corporation), Dan Feaster, PhD (Florida Node Alliance), George Bigelow, PhD (Mid-Atlantic Node).

Additional Resources:

• Download slides (pptx)